arrow
D

Dimana Dimitrova

national institutes of health
H指数:17
被引数:918

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Membranous Conjunctivitis in Acute and Chronic Graft-Versus-Host Disease: Longitudinal Ocular Outcomes

膜性结膜炎在急性与慢性移植物抗宿主病中的纵向眼部结局

2026-10-220
OA
Allogeneic hematopoietic cell transplantation in mature T- or NK-lymphomas: a phase II clinical trial

成熟T或NK淋巴瘤的同种异体造血细胞移植: II期临床试验

2026-04-230
OAAI
Allogeneic hematopoietic cell transplantation for partial RAG deficiency in children and adults: excellent outcomes with a reduced intensity, posttransplantation cyclophosphamide-based approach

异基因造血细胞移植治疗儿童及成人部分RAG缺乏症:采用减低强度、基于移植后环磷酰胺的方法可获得优异效果

2026-02-280
OAAI
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis

CXCL9作为一种新型预后标志物,用于识别患有噬血细胞性淋巴组织细胞增多症的成人高风险群体。

Blood
IF23.1
2026-02-263
PRE
Cryptosporidiosis in Inborn Errors of Immunity: A Single Center Cohort and Review of the Literature

免疫缺陷病中的隐孢子虫病:一项单中心队列研究及文献综述

2026-01-010
PRE
Usefulness and Limitations of Polymerase Chain Reaction (PCR) for the Diagnosis and Management of Toxoplasmosis Following Allogeneic Hematopoietic Cell Transplant: Single-center Experience With 31 Patients Over 16 Years

聚合酶链式反应(PCR)在异基因造血细胞移植后弓形虫病诊断与管理中的有效性与局限性:单中心16年经验,涉及31例患者

2025-08-050
OAAI
Restoration of the human skin microbiome following immune recovery after hematopoietic stem cell transplantation

造血干细胞移植后免疫恢复期间人体皮肤微生物组的恢复

2025-07-280
OAAI
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study

异基因造血干细胞移植治疗STAT3高IgE综合征:一项全球性研究

2025-06-230
OAAI
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation

供者年龄和供者巨细胞病毒血清状态对亲属供者异基因造血干细胞移植后结局的影响

2025-03-120
PRE
Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature

多组学分析揭示人类RAG缺陷症表现出独特的免疫失调模式,但具有共同的炎症特征

2025-01-010
OA
Understanding Barriers to Hematopoietic Cell Transplant (HCT) Access: Socio-Demographic Characteristics and Area Deprivation Index (ADI) of Patients Referred to the National Institutes of Health (NIH) for HCT

理解造血细胞移植(HCT)准入的障碍:转诊至美国国立卫生研究院(NIH)进行HCT的患者的社会经济特征及区域剥夺指数(ADI)

BLOOD
IF23.1
2024-11-050
PRE
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals

免疫功能正常和免疫功能低下的个体对SARS-CoV-2的反应对T细胞受体库的扰动

2024-06-013
PRE
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients
2024-02-1610
OAAI
Separating the Wheat From the Chaff in Asthma and Bronchiectasis: The Saga Trajectory of a Patient With Adult-Onset RAG1 Deficiency
2023-06-011
PRE
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients (vol 41, pg 1633, 2021)
2022-04-301
OAAI
The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort

腺苷脱氨酶2缺乏的谱: 对60例患者队列的观察性分析

2022-01-1051
OAAI